Health Care
GAIN THERAPEUTICS INC GANX
$2.03
Price at quarter end (Q3 2026)
Superinvestor owners
1
Rank #1550 by number of owners
% of all portfolios
0.00%
Rank #1541 by combined value
Net managers Q2 2026
0
No one entered or exited
Hold price
—
Weighted avg. reported price
Largest position
0.0%
of David Einhorn's portfolio
Live price
Compare with the quarter-end price of $2.03 reported in the 13F
Superinvestors holding GANX
| Recent activity | |||
|---|---|---|---|
| David Einhorn · Greenlight Capital (DME Capital Management) | 0.0% | — | $1.1M |